Korro Bio shares drop after KRRO-110 trial in AATD misses protein goals; company cuts 34% of staff and shifts focus to ...
Zacks Investment Research on MSN
Are Investors Undervaluing American Assets Trust (AAT) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
From campaign trails to global boardrooms, AAT has earned a reputation for accomplishing some of the most complex private ...
Amphista Therapeutics has announced the appointment of three new senior leaders: Dr Lisa Butler, Senior Vice President of ...
Investors might want to bet on American Assets Trust (AAT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...
American Assets Trust (AAT) posted net profit margins of 14.1%, up from 12.9% a year ago, while earnings rose 5.4% over the past year, which is well below its 5-year average growth rate of 21.6% per ...
INLIGHT is currently ongoing at multiple trial sites, including in the US following clearance of an Investigational New Drug (IND) application. Wave has expanded Cohort 2, Cohort 3, and Cohort 4 (600 ...
AAT (The Association of Accounting Technicians) has been approved as the first accountancy professional body to join the South Yorkshire Skills Bank and will provide financial training to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results